Concepedia

Diana M. Brainard

DM

164

Publications

25.9K

Citations

72

H-Index

2004

Active since

Affiliations

Gilead Sciences (United States)(Current)

Texas Liver Institute

Johns Hopkins University

The University of Texas Health Science Center at San Antonio

Johns Hopkins Medicine

Diana M. Brainard is an author at Gilead Sciences (United States) specializing in medicine, hepatitis, and viral hepatitis.

Top concepts

Publications per year

2004–2023

164

Publications

164

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Jonathan Grein, Norio Ohmagari, Daniel D. Shin et al. · New England Journal of Medicine · 2020 · 2.9K citations · Full text

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

Eric Lawitz, Alessandra Mangia, David Wyles et al. · New England Journal of Medicine · 2013 · 1.8K citations

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman, David Chien Lye, David S.C. Hui et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19

Christoph D. Spinner, Robert Gottlieb, Gerard J. Criner et al. · JAMA · 2020 · 1.3K citations · Full text

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

Jordan J. Feld, Ira M. Jacobson, Christophe Hézode et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

Rows per page

1–5 of 164